CC BY-NC-ND 4.0 · Geburtshilfe Frauenheilkd 2018; 78(12): 1219-1231
DOI: 10.1055/a-0659-2596
GebFra Science
Georg Thieme Verlag KG Stuttgart · New York

Gestational Diabetes Mellitus (GDM) – Diagnosis, Treatment and Follow-Up. Guideline of the DDG and DGGG (S3 Level, AWMF Registry Number 057/008, February 2018)

Article in several languages: English | deutsch
Ute Margaretha Schäfer-Graf
1   Perinatalzentrum, Klinik für Gynäkologie und Geburtshilfe, Berlin, Germany
Ulrich Gembruch
2   Obstetrics & Prenatal Medicine, Universitätsklinikum Bonn, Bonn, Germany
Franz Kainer
3   Geburtshilfe und Pränatalmedizin, Klinik Hallerwiese, Nürnberg, Germany
Tanja Groten
4   Klinik für Frauenheilkunde und Geburtshilfe, Universitätsklinikum Jena, Jena, Germany
Sandra Hummel
5   Diabetes, Helmholtz Zentrum München Deutsches Forschungszentrum für Umwelt und Gesundheit, Neuherberg, Germany
Irene Hösli
6   Obstetrics, University Hospital, Basel, Switzerland
Mellita Grieshop
7   Hebammenstudiengang, Evangelische Hochschule Berlin, Berlin, Germany
Matthias Kaltheuner
8   Diabetesschwerpunktpraxis, Leverkusen, Germany
Christoph Bührer
9   Neonatologie, Charite, Berlin, Germany
Alexandra Kautzky-Willer
10   Med. Universität Vienna, Wien, Austria
Katharina Laubner
11   Diabetes, Universität Freiburg, Freiburg, Germany
Dagmar Bancher-Todesca
12   Gynäkologie und Geburtshilfe, Universität Wien, Wien, Austria
› Author Affiliations
Further Information

Publication History

received 30 April 2018
revised 28 June 2018

accepted 16 July 2018

Publication Date:
14 December 2018 (online)


A team of experts from the fields of gynaecology and obstetrics, diabetology, internal medicine, paediatrics and midwifery from Germany, Austria and Switzerland produced a new version of the existing S3 guideline on gestational diabetes. It replaces the recommendations of the German Association for Gynaecology and Obstetrics and the German Diabetes Association on the diagnosis and treatment of gestational diabetes from 2011 and is valid for the three German-speaking countries. The primary aim of the guideline is to improve and standardise the prevention, screening, diagnosis, treatment and follow-up of gestational diabetes through evidence-based recommendations for the outpatient and inpatient area. A large number of new studies and data published in the last few years required a comprehensive revision of the 2011 guideline. The new aspects include early screening of pregnant women with a high risk for diabetes or gestational diabetes, the validity of two-stage screening in the third trimester by means of the 50-g challenge test, as specified in the maternity guidelines, use of metformin instead of or in addition to insulin in gestational diabetes, and birth planning with GDM and/or macrosomia. The recommendations are based on the evidence from the literature, which was selected through a systematic external literature search. All recommendations had to pass through a consensus process. The present text corresponds to the practice guideline on gestational diabetes, which is an action-oriented short version of the evidence-based S3 guideline that can be viewed on the internet.